ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026
[Explore the potential diagnostic markers of primary Sjögren syndrome by bioinformatics combined with machine learning].
Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a diagnostic model for primary Sjögren syndrome (pSS) utilizing transcriptomics-based machine learning techniques, and to explore potential therapeutic targets.
methodsWe selected patients diagnosed with pSS and control subjects with salivary gland samples from the Gene Expression Omnibus (GEO) database for transcriptome sequencing. This was complemented by methylation sequencing data, followed by weighted gene co-expression network analysis (WGCNA) in conjunction with clinical data to identify candidate diagnostic genes. Subsequently, we refined the gene list using least absolute shrinkage and selection operator (LASSO), random forest (RF), Gaussian mixed model (GMM), and support vector machine (SVM). Ultimately, we constructed a composite diagnostic model for pSS employing SVM, neural networks (NN), Logistic regression (LR), decision trees (DT), adaptive boosting (AdaBoost), bootstrap aggregating (Bagging), random forest, and Naive Bayes classifiers, totaling eight distinct machine learning algorithms, and predicted drug targets.
resultsThrough differential gene screening combined with WGCNA analysis of the GEO database, we identified 12 key genes. Further variable selection
conclusionThis research identifies
Indexed as
Identifiers
42880922PMC13672237What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.